Wilton A - Search Results

1

Tumor associated endothelial expression of B7-H3 predicts survival in ovarian carcinomas.

Zang X, Sullivan PS, Soslow RA, Waitz R, Reuter VE, Wilton A, Thaler HT, Arul M, Slovin SF, Wei J, Spriggs DR, Dupont J, Allison JP. Zang X, et al. Among authors: wilton a. Mod Pathol. 2010 Aug;23(8):1104-12. doi: 10.1038/modpathol.2010.95. Epub 2010 May 21. Mod Pathol. 2010. PMID: 20495537 Free PMC article.

2

Clinicopathologic analysis of 187 high-grade endometrial carcinomas of different histologic subtypes: similar outcomes belie distinctive biologic differences.

Soslow RA, Bissonnette JP, Wilton A, Ferguson SE, Alektiar KM, Duska LR, Oliva E. Soslow RA, et al. Among authors: wilton a. Am J Surg Pathol. 2007 Jul;31(7):979-87. doi: 10.1097/PAS.0b013e31802ee494. Am J Surg Pathol. 2007. PMID: 17592263

3

Time to detectable metastatic disease in patients with rising prostate-specific antigen values following surgery or radiation therapy.

Slovin SF, Wilton AS, Heller G, Scher HI. Slovin SF, et al. Clin Cancer Res. 2005 Dec 15;11(24 Pt 1):8669-73. doi: 10.1158/1078-0432.CCR-05-1668. Clin Cancer Res. 2005. PMID: 16361552

4

Radiation-associated endometrial cancers are prognostically unfavorable tumors: a clinicopathologic comparison with 527 sporadic endometrial cancers.

Pothuri B, Ramondetta L, Eifel P, Deavers MT, Wilton A, Alektiar K, Barakat R, Soslow RA. Pothuri B, et al. Among authors: wilton a. Gynecol Oncol. 2006 Dec;103(3):948-51. doi: 10.1016/j.ygyno.2006.05.039. Epub 2006 Jul 25. Gynecol Oncol. 2006. PMID: 16870239

5

Phase I/II study of weekly paclitaxel plus carboplatin and gemcitabine as first-line treatment of advanced-stage ovarian cancer: pathologic complete response and longitudinal assessment of impact on cognitive functioning.

Hensley ML, Correa DD, Thaler H, Wilton A, Venkatraman E, Sabbatini P, Chi DS, Dupont J, Spriggs D, Aghajanian C. Hensley ML, et al. Among authors: wilton a. Gynecol Oncol. 2006 Aug;102(2):270-7. doi: 10.1016/j.ygyno.2005.12.042. Epub 2006 Feb 20. Gynecol Oncol. 2006. PMID: 16490239 Clinical Trial.

6

A polyvalent vaccine for high-risk prostate patients: "are more antigens better?".

Slovin SF, Ragupathi G, Fernandez C, Diani M, Jefferson MP, Wilton A, Kelly WK, Morris M, Solit D, Clausen H, Livingston P, Scher HI. Slovin SF, et al. Among authors: wilton a. Cancer Immunol Immunother. 2007 Dec;56(12):1921-30. doi: 10.1007/s00262-007-0335-y. Epub 2007 Jul 10. Cancer Immunol Immunother. 2007. PMID: 17619878 Free PMC article. Clinical Trial.

7

Anti-epidermal growth factor receptor monoclonal antibody cetuximab plus Doxorubicin in the treatment of metastatic castration-resistant prostate cancer.

Slovin SF, Kelly WK, Wilton A, Kattan M, Myskowski P, Mendelsohn J, Scher HI. Slovin SF, et al. Among authors: wilton a. Clin Genitourin Cancer. 2009 Oct;7(3):E77-82. doi: 10.3816/CGC.2009.n.028. Clin Genitourin Cancer. 2009. PMID: 19815486 Clinical Trial.

8

A comprehensive comparison of the continual reassessment method to the standard 3 + 3 dose escalation scheme in Phase I dose-finding studies.

Iasonos A, Wilton AS, Riedel ER, Seshan VE, Spriggs DR. Iasonos A, et al. Among authors: wilton as. Clin Trials. 2008;5(5):465-77. doi: 10.1177/1740774508096474. Clin Trials. 2008. PMID: 18827039 Free PMC article.

9

A bivalent conjugate vaccine in the treatment of biochemically relapsed prostate cancer: a study of glycosylated MUC-2-KLH and Globo H-KLH conjugate vaccines given with the new semi-synthetic saponin immunological adjuvant GPI-0100 OR QS-21.

Slovin SF, Ragupathi G, Fernandez C, Jefferson MP, Diani M, Wilton AS, Powell S, Spassova M, Reis C, Clausen H, Danishefsky S, Livingston P, Scher HI. Slovin SF, et al. Vaccine. 2005 May 2;23(24):3114-22. doi: 10.1016/j.vaccine.2005.01.072. Vaccine. 2005. PMID: 15837210

10

Androgen deprivation for minimal metastatic disease: threshold for achieving undetectable prostate-specific antigen.

Beekman K, Morris M, Slovin S, Heller G, Wilton A, Bianco F Jr, Scardino PT, Scher HI. Beekman K, et al. Among authors: wilton a. Urology. 2005 May;65(5):947-52. doi: 10.1016/j.urology.2004.12.012. Urology. 2005. PMID: 15882729

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

229 results

Search Page

Filters